Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-20-008746
Filing Date
2020-08-11
Accepted
2020-08-10 21:01:03
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT cvm_10qa.htm   iXBRL 10-Q/A 966335
2 CERTIFICATIONS cvm_ex31.htm EX-31 14864
3 IN CONNECTION WITH THE QUARTERLY REPORT OF CEL-SCI CORPORATION (THE COMPANY ) ON cvm_ex32.htm EX-32 3261
  Complete submission text file 0001654954-20-008746.txt   4936829

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cvm-20200630.xsd EX-101.SCH 54086
5 XBRL CALCULATION FILE cvm-20200630_cal.xml EX-101.CAL 45141
6 XBRL DEFINITION FILE cvm-20200630_def.xml EX-101.DEF 120455
7 XBRL LABEL FILE cvm-20200630_lab.xml EX-101.LAB 299983
8 XBRL PRESENTATION FILE cvm-20200630_pre.xml EX-101.PRE 239812
9 EXTRACTED XBRL INSTANCE DOCUMENT cvm_10qa_htm.xml XML 998443
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-11889 | Film No.: 201090881
SIC: 2836 Biological Products, (No Diagnostic Substances)